Abstract
The aim of this study was to investigate pretreatment prognostic factors that could be useful in predicting the response to plasma exchange in thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS). Thirty-two patients with TTP/HUS, treated with plasma exchange at our institution from 1980 to 1994, were studied. The main clinical and laboratory data at the beginning of plasma exchanges were analyzed by the Cox stepwise logistic regression, applied to either treatment failure or death. Seventeen (53%) patients attained a complete remission and 22 (69%) survived (five in advanced renal failure and long-term hemodialysis). Longer delay in initiating plasma exchanges, presence of stupor or coma, and higher creatinine levels at the beginning of plasma exchanges were independent predictors of treatment failure. Stupor or coma at the beginning of plasma exchanges was the only predictor of mortality from unremitted TTP/HUS. Hemoglobin levels, platelet count, and LDH activity, traditionally envisaged as markers of disease activity, neither correlated with previous duration of TTP/HUS nor had any prognostic value. Early diagnosis of TTP/HUS and prompt initiation of intensive plasma exchange emerged from this study as the most effective interventions for improving the prognosis of TTP/HUS patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Amorosi EL, Ultmann JE (1966) Thrombotic thrombocytopenic purpura: report of 16 cases and review of the literature. Medicine (Baltimore) 45:139–159
Bergstein JM, Riley M, Bang NU (1992) Role of plasminogenactivator inhibitor type 1 in the pathogenesis and outcome of the hemolytic uremic syndrome. N Engl J Med 327:755–759
Blitzer JB, Granfortuna JM, Gottlieb AJ et al. (1987) Thrombotic thrombocytopenic purpura: treatment with plasmapheresis. Am J Hematol 24:329–339
Byrnes JJ, Moake JL (1986) Thrombotic thrombocytopenic purpura and the haemolytic-uraemic syndrome: evolving concepts of pathogenesis and therapy. Clin Haematol 15:413–442
Byrnes JJ, Moake JL, Klug P, Periman Ph (1990) Effectiveness of the cryosupernatant fraction of plasma in the treatment of refractory thrombotic thrombocytopenic purpura. Am J Hematol 34:169–174
Cox DR (1970) The analysis of binary data. Mathew and Co., London, pp 90–98
Hayward CPM, Sutton DMC, Carter WHC et al. (1994) Treatment outcomes in patients with adult thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Arch Intern Med 154:982–987
Henon P (1991) Traitement du purpura thrombotic thrombopenique. Press Med 20:1761–1767
Kay AC, Solberg LA, Nichols DA, Pettit RM (1991) Prognostic significance of computed tomography of the brain in thrombotic thrombocytopenic purpura. Mayo Clin Proc 66:602–607
Kennedy SS, Zacharski LR, Beck JR (1980) Thrombotic thrombocytopenic purpura: analysis of 48 unselected cases. Semin Thromb Hemost 6:341–349
Kwaan HC (1987) Role of fibrinolysis in thrombotic thrombocytopenic purpura. Semin Hematol 24:101–109
Levin M, Grunwald HW (1991) Use of vincristine in refractory thrombotic thrombocytopenic purpura. Acta Hematol 85:37–40
Lian EC, Siddiqui FA, Jamieson GA, Tandon NN (1991) Platelet agglutinating protein p37 causes platelet agglutination through its binding to membrane glycoprotein IV. Thromb Hemost 65:102–106
Moake JL, McPherson PD (1989) Abnormalities of von Willebrand multimers in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. Am J Med 89:3.9N-3.15N
Monteagudo J, Pereira A, Reverter JC et al. (1991) Thrombin generation and fibrinolysis in the thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome. Thromb Hemost 66:515–519
Onudarson PT, Rowe JM, Heal JM, Francis CW (1991) Response to plasma exchange and splenectomy in thrombotic thrombocytopenic purpura: a 10-year experience at a single institution. Arch Intern Med 152:791–796
Pereira A, Monteagudo J, Bono A, López-Guillermo A, Ordinas A (1993) Effect of splenectomy on von Willebrand factor multimeric structure in thrombotic thrombocytopenic purpura refractory to plasma exchange. Blood Coag Fibrin 4:783–786
Pettit RM (1980) Thrombotic thrombocytopenic purpura: a 30-year review. Semin Thromb Hemost 6:350–355
Remuzzi G (1987) HUS and TTP: variable expression of a single entity. Kidney Int 32:292–308
Remuzzi G, Zoja C, Rossi E (1987) Prostacyclin in thrombotic microangiopathy. Semin Hematol 24:110–118
Rock GA, Shumak KH, Buskard NA et al. (1991) Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med 325:393–397
Rock G, Shumak K, Kelton VS et al. (1992) Thrombotic thrombocytopenic purpura: outcome in 24 patients wiht renal impairment treated with plasma exchange. Transfusion 32:710–714
Rose M, Eldor A (1987) High incidence of relapses in thrombotic thrombocytopenic purpura: clinical study of 38 patients. Am J Hematol 83:437–444
Thomson CE, Damon LIE, Ries CA, Linker CA (1992) Thrombotic microangiopathies in the 1980s: clinical features, response to treatment, and impact of the human immunodeficiency virus epidemic. Blood 80:1890–1895
Vianelli N, Sermasi G, D'Alessandro R et al. (1991) Prompt plasma-exchange treatment and coma reversibility in two patients with thrombotic thrombocytopenic purpura. Haematologica (Pavia) 76:72–74
Author information
Authors and Affiliations
Additional information
This work has been supported by grant FIS 94/1098 from the Ministerio de Sanidad y Consumo of Spain
Rights and permissions
About this article
Cite this article
Pereira, A., Mazzara, R., Monteagudo, J. et al. Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: a multivariate analysis of factors predicting the response to plasma exchange. Ann Hematol 70, 319–323 (1995). https://doi.org/10.1007/BF01696619
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01696619